The results of other studies show that a lysozyme, together with lactoferrin and immunoglobulin, can inhibit the growth of gastrointestinal pathogenic microorganisms and reduce the incidence of gastrointestinal infection in infants [12]. Here, LYZ is linked to digestive system infectious disorder.